Recombinant Factor IX
- 1 January 1997
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 78 (01), 261-265
- https://doi.org/10.1055/s-0038-1657536
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Transmission of symptomatic parvovirus B19 infection by clotting factor concentrateBritish Journal of Haematology, 1996
- Parvovirus B19 infection in patients with hemophiliaTransfusion, 1996
- Comparison of the recovery and half‐life of a high‐purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study GroupTransfusion, 1995
- Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting‐factor concentrates considered safe against human immunodeficiency and hepatitis C virusesHaemophilia, 1995
- Acute hepatitis A in haemophiliacsThe Lancet, 1992
- Coagulation factor IX: Successful surgical experience with a purified factor IX concentrateAmerican Journal of Hematology, 1992
- Outbreak of hepatitis A among Italian patients with haemophiliaThe Lancet, 1992